Yangliu Xia
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Pharmacological Effects of Natural Compounds
Papers in
-
- Biochemical and Molecular Research 5
- PI3K/AKT/mTOR signaling in cancer 5
- Pharmacology 24
- Pharmacogenetics and Drug Metabolism 18
- Pharmacological Effects of Natural Compounds 6
- Drug-Induced Hepatotoxicity and Protection 4
- Co-authors
- Frank J. Gonzalez (12 shared papers)Ping Wang (14 shared papers)Guang‐Bo Ge (25 shared papers)Ling Yang (22 shared papers)Nana Yan (7 shared papers)Tingting Yan (6 shared papers)Haiping Hao (6 shared papers)Yong Liu (19 shared papers)
- Journals
- Xenobiotica (5 papers)Chemico-Biological Interactions (4 papers)RSC Advances (4 papers)Acta Pharmaceutica Sinica B (3 papers)Toxicology and Applied Pharmacology (3 papers)
- Partner nations
- ChinaUnited StatesFinland
In The Last Decade
Yangliu Xia
55 papers receiving 989 citations
Peers
Comparison fields: 5 of 96
- Pharmacology 223
- Complementary and alternative medicine 70
- Pharmacology 102
- Biochemistry 43
- Oncology 142
Countries citing papers authored by Yangliu Xia
This map shows the geographic impact of Yangliu Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangliu Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangliu Xia more than expected).
Fields of papers citing papers by Yangliu Xia
This network shows the impact of papers produced by Yangliu Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangliu Xia. The network helps show where Yangliu Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Yangliu Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 175 | |
| 2 | 2019 | 102 | |
| 3 | 2018 | 72 | |
| 4 | 2017 | 43 | |
| 5 | 2021 | 42 | |
| 6 | 2013 | 30 | |
| 7 | 2021 | 29 | |
| 8 | 2021 | 26 | |
| 9 | 2020 | 25 | |
| 10 | 2018 | 25 | |
| 11 | 2021 | 25 | |
| 12 | 2016 | 24 | |
| 13 | 2021 | 23 | |
| 14 | 2015 | 23 | |
| 15 | 2015 | 20 | |
| 16 | 2020 | 18 | |
| 17 | 2015 | 17 | |
| 18 | 2020 | 16 | |
| 19 | 2021 | 16 | |
| 20 | 2015 | 15 |
About Yangliu Xia
Yangliu Xia is a scholar working on Molecular Biology, Pharmacology, Pharmacology, Oncology and Plant Science, having authored 55 papers that have together received 1.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (18 papers), Pharmacological Effects of Natural Compounds (6 papers), Biochemical and Molecular Research (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Drug Transport and Resistance Mechanisms (5 papers), Electrochemical sensors and biosensors (5 papers), Phytochemistry and Biological Activities (4 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). The work is most often cited by research in Pharmacology (223 citations), Complementary and alternative medicine (70 citations), Pharmacology (102 citations), Biochemistry (43 citations) and Oncology (142 citations). Yangliu Xia has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Frank J. Gonzalez, Ping Wang, Guang‐Bo Ge, Ling Yang, Nana Yan, Tingting Yan, Haiping Hao, Yong Liu, Guangji Wang and Xia Lv. Their work appears in journals such as Xenobiotica, Chemico-Biological Interactions, RSC Advances, Acta Pharmaceutica Sinica B and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.